Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis

Objective: The objective of our study is to investigate the Fc glycosylation profiles of both antigen-specific IgG targeted against proteinase 3 (PR3-ANCA) and total IgG as prognostic markers of relapse in patients with Granulomatosis with Polyangiitis (GPA). Methods: Seventy-five patients with GPA...

Full description

Bibliographic Details
Main Authors: Michael J. Kemna, Rosina Plomp, Pieter van Paassen, Carolien A.M. Koeleman, Bas C. Jansen, Jan G.M.C. Damoiseaux, Jan Willem Cohen Tervaert, Manfred Wuhrer
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396417300373
_version_ 1818129978391265280
author Michael J. Kemna
Rosina Plomp
Pieter van Paassen
Carolien A.M. Koeleman
Bas C. Jansen
Jan G.M.C. Damoiseaux
Jan Willem Cohen Tervaert
Manfred Wuhrer
author_facet Michael J. Kemna
Rosina Plomp
Pieter van Paassen
Carolien A.M. Koeleman
Bas C. Jansen
Jan G.M.C. Damoiseaux
Jan Willem Cohen Tervaert
Manfred Wuhrer
author_sort Michael J. Kemna
collection DOAJ
description Objective: The objective of our study is to investigate the Fc glycosylation profiles of both antigen-specific IgG targeted against proteinase 3 (PR3-ANCA) and total IgG as prognostic markers of relapse in patients with Granulomatosis with Polyangiitis (GPA). Methods: Seventy-five patients with GPA and a PR3-ANCA rise during follow-up were included, of whom 43 patients relapsed within a median period of 8 (2–16) months. The N-glycan at Asn297 of affinity-purified and denatured total IgG and PR3-ANCA was determined by mass spectrometry of glycopeptides in samples obtained at the time of the PR3-ANCA rise and at the time of the relapse or time-matched during remission. Results: Patients with total IgG1 exhibiting low galactosylation or low sialylation were highly prone to relapse after an ANCA rise (HR 3.46 [95%-CI 1.73–6.96], p < 0.0001 and HR 3.22 [95%-CI 1.52–6.83], p = 0.002, respectively). In relapsing patients, total IgG1 galactosylation, sialylation and bisection significantly decreased and fucosylation significantly increased from the time of the PR3-ANCA rise to the relapse (p < 0.0001, p = 0.0087, p < 0.0001 and p = 0.0025), while the glycosylation profile remained similar in non-relapsing patients. PR3-ANCA IgG1 galactosylation, sialylation and fucosylation of PR3-ANCA IgG1 decreased in relapsing patients (p = 0.0073, p = 0.0049 and p = 0.0205), but also in non-relapsing patients (p = 0.0007, p = 0.0114 and p = 0.0002), while bisection increased only in non-relapsing patients (p < 0.0001). Conclusion: While Fc glycosylation profiles have been associated with clinically manifest autoimmune diseases, in the present study we show that low galactosylation and sialyation in total IgG1 but not PR3-ANCA IgG1 predicts disease reactivation in patients with GPA who experience an ANCA rise during follow-up. We postulate that glycosylation profiles may be useful in pre-emptive therapy studies using ANCA rises as guideline.
first_indexed 2024-12-11T07:57:44Z
format Article
id doaj.art-bbe80d4a90ea4097a03cd23d9193992b
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-12-11T07:57:44Z
publishDate 2017-03-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-bbe80d4a90ea4097a03cd23d9193992b2022-12-22T01:15:12ZengElsevierEBioMedicine2352-39642017-03-0117C10811810.1016/j.ebiom.2017.01.033Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated VasculitisMichael J. Kemna0Rosina Plomp1Pieter van Paassen2Carolien A.M. Koeleman3Bas C. Jansen4Jan G.M.C. Damoiseaux5Jan Willem Cohen Tervaert6Manfred Wuhrer7Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The NetherlandsCentral Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, The NetherlandsCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The NetherlandsCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The NetherlandsCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The NetherlandsCentral Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, The NetherlandsCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The NetherlandsCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The NetherlandsObjective: The objective of our study is to investigate the Fc glycosylation profiles of both antigen-specific IgG targeted against proteinase 3 (PR3-ANCA) and total IgG as prognostic markers of relapse in patients with Granulomatosis with Polyangiitis (GPA). Methods: Seventy-five patients with GPA and a PR3-ANCA rise during follow-up were included, of whom 43 patients relapsed within a median period of 8 (2–16) months. The N-glycan at Asn297 of affinity-purified and denatured total IgG and PR3-ANCA was determined by mass spectrometry of glycopeptides in samples obtained at the time of the PR3-ANCA rise and at the time of the relapse or time-matched during remission. Results: Patients with total IgG1 exhibiting low galactosylation or low sialylation were highly prone to relapse after an ANCA rise (HR 3.46 [95%-CI 1.73–6.96], p < 0.0001 and HR 3.22 [95%-CI 1.52–6.83], p = 0.002, respectively). In relapsing patients, total IgG1 galactosylation, sialylation and bisection significantly decreased and fucosylation significantly increased from the time of the PR3-ANCA rise to the relapse (p < 0.0001, p = 0.0087, p < 0.0001 and p = 0.0025), while the glycosylation profile remained similar in non-relapsing patients. PR3-ANCA IgG1 galactosylation, sialylation and fucosylation of PR3-ANCA IgG1 decreased in relapsing patients (p = 0.0073, p = 0.0049 and p = 0.0205), but also in non-relapsing patients (p = 0.0007, p = 0.0114 and p = 0.0002), while bisection increased only in non-relapsing patients (p < 0.0001). Conclusion: While Fc glycosylation profiles have been associated with clinically manifest autoimmune diseases, in the present study we show that low galactosylation and sialyation in total IgG1 but not PR3-ANCA IgG1 predicts disease reactivation in patients with GPA who experience an ANCA rise during follow-up. We postulate that glycosylation profiles may be useful in pre-emptive therapy studies using ANCA rises as guideline.http://www.sciencedirect.com/science/article/pii/S2352396417300373PR3-ANCA associated vasculitisGranulomatosis with PolyangiitisGlycosylationGlycopeptideImmunoglobulinMass spectrometry
spellingShingle Michael J. Kemna
Rosina Plomp
Pieter van Paassen
Carolien A.M. Koeleman
Bas C. Jansen
Jan G.M.C. Damoiseaux
Jan Willem Cohen Tervaert
Manfred Wuhrer
Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis
EBioMedicine
PR3-ANCA associated vasculitis
Granulomatosis with Polyangiitis
Glycosylation
Glycopeptide
Immunoglobulin
Mass spectrometry
title Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis
title_full Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis
title_fullStr Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis
title_full_unstemmed Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis
title_short Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis
title_sort galactosylation and sialylation levels of igg predict relapse in patients with pr3 anca associated vasculitis
topic PR3-ANCA associated vasculitis
Granulomatosis with Polyangiitis
Glycosylation
Glycopeptide
Immunoglobulin
Mass spectrometry
url http://www.sciencedirect.com/science/article/pii/S2352396417300373
work_keys_str_mv AT michaeljkemna galactosylationandsialylationlevelsofiggpredictrelapseinpatientswithpr3ancaassociatedvasculitis
AT rosinaplomp galactosylationandsialylationlevelsofiggpredictrelapseinpatientswithpr3ancaassociatedvasculitis
AT pietervanpaassen galactosylationandsialylationlevelsofiggpredictrelapseinpatientswithpr3ancaassociatedvasculitis
AT carolienamkoeleman galactosylationandsialylationlevelsofiggpredictrelapseinpatientswithpr3ancaassociatedvasculitis
AT bascjansen galactosylationandsialylationlevelsofiggpredictrelapseinpatientswithpr3ancaassociatedvasculitis
AT jangmcdamoiseaux galactosylationandsialylationlevelsofiggpredictrelapseinpatientswithpr3ancaassociatedvasculitis
AT janwillemcohentervaert galactosylationandsialylationlevelsofiggpredictrelapseinpatientswithpr3ancaassociatedvasculitis
AT manfredwuhrer galactosylationandsialylationlevelsofiggpredictrelapseinpatientswithpr3ancaassociatedvasculitis